126 related articles for article (PubMed ID: 2538693)
1. Opioid binding properties of the purified kappa receptor from human placenta.
Ahmed MS; Zhou DH; Cavinato AG; Maulik D
Life Sci; 1989; 44(13):861-71. PubMed ID: 2538693
[TBL] [Abstract][Full Text] [Related]
2. Characterization of solubilized opiate receptors from human placenta.
Ahmed MS
Membr Biochem; 1983; 5(1):35-47. PubMed ID: 6316106
[TBL] [Abstract][Full Text] [Related]
3. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
Stojilković SS; Dufau ML; Catt KJ
Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human placental opioid receptors by 3H-ethylketocyclazocine and 3H-naloxone binding.
Agbas A; Simon J; Avni Oktem H; Varga E; Borsodi A
Neuropeptides; 1988 Oct; 12(3):171-6. PubMed ID: 2907370
[TBL] [Abstract][Full Text] [Related]
5. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites.
Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
J Neurochem; 1985 Sep; 45(3):688-99. PubMed ID: 2993510
[TBL] [Abstract][Full Text] [Related]
6. Interaction between [3H]ethylketocyclazocine and [3H]etorphine and opioid receptors in membranes from rat brain. A kinetic analysis.
Fischel SV; Medzihradsky F
Neuropharmacology; 1986 Apr; 25(4):351-9. PubMed ID: 3012397
[TBL] [Abstract][Full Text] [Related]
7. Photoaffinity labeling of opiate receptors using intrinsically photoactive 3H-opiates.
Kooper GN; Levinson NR; Copeland CF; Bowen WD
Mol Pharmacol; 1988 Mar; 33(3):316-26. PubMed ID: 2832721
[TBL] [Abstract][Full Text] [Related]
8. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
Chow T; Zukin RS
Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
[TBL] [Abstract][Full Text] [Related]
9. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
Devlin T; Shoemaker WJ
J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
[TBL] [Abstract][Full Text] [Related]
10. [3H]Mr 2034 labels a high affinity opioid kappa-receptor not accessible to naloxazone.
Ensinger HA
Eur J Pharmacol; 1983 Apr; 89(1-2):143-7. PubMed ID: 6305681
[TBL] [Abstract][Full Text] [Related]
11. Kappa opiate binding sites in human placenta.
Porthé G; Valette A; Cros J
Biochem Biophys Res Commun; 1981 Jul; 101(1):1-6. PubMed ID: 6116490
[No Abstract] [Full Text] [Related]
12. Characteristics of opioid receptors in guinea-pig cerebellum and human placenta.
Ishizuka Y; Oka T; Kenjo T; Fujii A
Tokai J Exp Clin Med; 1986 Aug; 11(3):179-84. PubMed ID: 3039693
[TBL] [Abstract][Full Text] [Related]
13. Kappa opioid receptors in human lumbo-sacral spinal cord.
Gouardères C; Kopp N; Cros J; Quirion R
Brain Res Bull; 1986 Mar; 16(3):355-61. PubMed ID: 3011219
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a kappa-opioid receptor on pituitary astrocytes: an autoradiographic study.
Bunn SJ; Hanley MR; Wilkin GP
Neurosci Lett; 1985 Apr; 55(3):317-23. PubMed ID: 2989733
[TBL] [Abstract][Full Text] [Related]
15. Resolution in the receptor binding of putative mu and kappa opiates.
Medzihradsky F; Dahlstrom PJ; Woods JH; Fischel SV; Mitsos SE
Life Sci; 1984 May; 34(22):2129-38. PubMed ID: 6145076
[TBL] [Abstract][Full Text] [Related]
16. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
Meunier JC; Kouakou Y; Puget A; Moisand C
Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
[TBL] [Abstract][Full Text] [Related]
17. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
18. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
Ensinger HA
Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
[TBL] [Abstract][Full Text] [Related]
19. Selective protection of benzomorphan binding sites against inactivation by N-ethylmaleimide. Evidence for kappa-opioid receptors in frog brain.
Zawilska J; Lajtha A; Borsodi A
J Neurochem; 1988 Sep; 51(3):736-9. PubMed ID: 2900875
[TBL] [Abstract][Full Text] [Related]
20. Relation of diltiazem binding sites to opioid receptor subtypes in the guinea-pig brain.
Ishizuka Y; Oka T
Tokai J Exp Clin Med; 1987 Mar; 12(1):11-7. PubMed ID: 2835832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
